Onderneming Syndax Pharmaceuticals, Inc.
Aandelen
SNDX
US87164F1057
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
20,79 USD | -0,86% | +0,24% | -3,79% |
Vakgebied
Aantal werknemers: 184
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Michael Metzger
CEO | Chief Executive Officer | 53 | 05-05-15 |
Peter Ordentlich
FOU | Founder | 55 | 11-10-05 |
Neil Gallagher
PSD | President | 60 | 10-04-23 |
Keith Goldan
DFI | Director of Finance/CFO | 52 | 13-06-22 |
Chief Tech/Sci/R&D Officer | 52 | - | |
Briggs Morrison
CTO | Chief Tech/Sci/R&D Officer | 65 | 15-06-15 |
Sharon P. Klahre
IRC | Investor Relations Contact | - | 13-06-22 |
Anjali Ganguli
PRN | Corporate Officer/Principal | 48 | 01-05-15 |
Kevin McManus
HRO | Human Resources Officer | - | 01-05-23 |
Luke Albrecht
LAW | General Counsel | 45 | 01-08-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 29-03-17 |
Dennis Podlesak
CHM | Chairman | 66 | 01-12-08 |
Pierre Legault
BRD | Director/Board Member | 63 | 04-01-17 |
William Meury
BRD | Director/Board Member | 56 | 25-09-18 |
Briggs Morrison
CTO | Chief Tech/Sci/R&D Officer | 65 | 15-06-15 |
Martin Huber
BRD | Director/Board Member | 64 | 15-09-21 |
Michael Metzger
CEO | Chief Executive Officer | 53 | 05-05-15 |
Jennifer Jarrett
BRD | Director/Board Member | 53 | 25-09-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 84 979 686 | 83 411 029 ( 98,15 %) | 0 | 98,15 % |
Bedrijfsgegevens
Syndax Pharmaceuticals, Inc.
35 Gatehouse Drive Building D
02451, Waltham
+781 419 1400
http://www.syndax.comSector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-3,79% | 1,77 mld. | |
+4,09% | 43,84 mld. | |
+46,06% | 41,25 mld. | |
+9,45% | 41,68 mld. | |
-10,92% | 27,04 mld. | |
+9,32% | 25,53 mld. | |
-24,87% | 18,18 mld. | |
+29,70% | 12,29 mld. | |
+1,28% | 12,29 mld. | |
+7,78% | 11,15 mld. |
- Beurs
- Aandelen
- Koers SNDX
- Onderneming Syndax Pharmaceuticals, Inc.